The purpose of this review is to summarize some of the biochemical or chemical findings that have contributed most significantly to our current understanding of the permeability barrier of the skin. This literature survey covers the period from the 1970s up to the present. This seems appropriate since earlier progress was comprehensively covered in a 1978 review by Bob Scheuplein entitled ‘Permeability of the skin: a review of major concepts' and in the earlier review by Scheuplein and Blank entitled ‘Permeability of the skin'. Both of these review articles are still being cited, and the earlier one has been cited more than 800 times. Overlap with material covered in these earlier publications will be minimized. The overall significance of findings from some of the most recent years may not yet be determined. The emphasis will be placed on the determination of the composition and structures of the epidermal lipids, especially those of the stratum corneum, key enzymes in the biosynthesis of these lipids and some of the physical chemical properties of these lipids as revealed by X-ray diffraction, infrared spectroscopy and other physical methods.

1.
Scheuplein RJ: Permeability of the skin: a review of major concepts. Curr Probl Dermatol 1978;7:172-186.
2.
Scheuplein RJ, Blank IH: Permeability of the skin. Physiol Rev 1971;51:702-747.
3.
Otberg N, Teichmann A, Rasuljev U, Sinkgraven R, Sterry W, Lademann J: Follicular penetration of topically applied caffeine via a shampoo formulation. Skin Pharmacol Physiol 2007;20:195-198.
4.
Liu X, Grice JE, Lademann J, Otberg N, Trauer S, Patzelt A, Roberts MS: Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man. Br J Clin Pharmacol 2011;72:768-774.
5.
Lademann J, Richter H, Schanzer S, Knorr F, Meinke M, Sterry W, Patzelt A: Penetration and storage of particles in human skin: perspectives and safety aspects. Eur J Pharm Biopharm 2011;77:465-468.
6.
Nemanic MK, Elias PM: In situ precipitation: a novel cytochemical technique for visualization of permeability pathways in mammalian stratum corneum. J Histochem Cytochem 1980;28:573-578.
7.
Squier CA, Lesch CA: Penetration pathways of different compounds through epidermis and oral epithelia. J Oral Pathol 1988;17:512-516.
8.
Gray GM, Yardley HJ: Different populations of pig epidermal cells: isolation and lipid composition. J Lipid Res 1975;16:441-447.
9.
Gray GM, Yardley HJ: Lipid compositions of cells isolated from pig, human and rat epidermis. J Lipid Res 1975;16:434-440.
10.
Gray GM, Yardley HJ: Mitochondria and nuclei of pig and human epidermis: isolation and lipid composition. J Invest Dermatol 1975;64:423-430.
11.
Gray GM, White RJ: Glycosphingolipids and ceramides in human and pig epidermis. J Invest Dermatol 1978;70:336-341.
12.
Gray GM, White RJ, Majer JR: 1-(3′′-O-acyl)-beta-glucosyl-N-dihydroxypentatriacontadienoylsphingosine, a major component of the glucosylceramides of pig and human epidermis. Biochim Biophys Acta 1978;528:127-137.
13.
Yardley HJ, Summerly R: Lipid composition and metabolism in normal and diseased epidermis. Pharmacol Ther 1981;13:357-383.
14.
Yardley HJ: Epidermal lipids. Int J Cosmet Sci 1987;9:13-19.
15.
Wertz PW, Swartzendruber DC, Madison KC, Downing DT: The composition and morphology of epidermal cyst lipids. J Invest Dermatol 1987;89:419-425.
16.
Bortz JT, Wertz PW, Downing DT: On the origin of alkanes found in human skin surface lipids. J Invest Dermatol 1989;93:723-727.
17.
Wertz PW, Norlen L: ‘Confidence intervals' for the ‘true' lipid composition of the human skin barrier? In Forslind B, Lindberg M (eds): Skin, Hair and Nails: Structure and Function. New York, Dekker, 2004.
18.
Wertz PW, Downing DT: Stratum corneum: biological and biochemical considerations. Drugs Pharm Sci 1989;35:1-22.
19.
Wertz PW, Downing DT: Acylglucosylceramides of pig epidermis: structure determination. J Lipid Res 1983;24:753-758.
20.
Abraham W, Wertz PW, Downing DT: Linoleate-rich acylglucosylceramides of pig epidermis: structure determination by proton magnetic resonance. J Lipid Res 1985;26:761-766.
21.
Wertz PW, Downing DT: Glycolipids in mammalian epidermis: structure and function in the water barrier. Science 1982;217:1261-1262.
22.
Wertz PW, Downing DT: Ceramides of pig epidermis: structure determination. J Lipid Res 1983;24:759-765.
23.
Wertz PW, Downing DT: Metabolism of linoleic acid in porcine epidermis. J Lipid Res 1990;31:1839-1844.
24.
Wertz PW, Downing DT: Covalently bound ω-hydroxyacylsphingosine in the stratum corneum. Biochim Biophys Acta 1987;917:108-111.
25.
Swartzendruber DC, Wertz PW, Madison KC, Downing DT: Evidence that the corneocyte has a chemically bound lipid envelope. J Invest Dermatol 1987;88:709-713.
26.
Wertz PW, Downing DT: Glucosylceramides of pig epidermis: structure determination. J Lipid Res 1983;24:1135-1139.
27.
Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R: Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1993;1182:147-151.
28.
Robson KJ, Stewart ME, Michelsen S, Lazo ND, Downing DT: 6-Hydroxy-4-sphingenine in human epidermal ceramides. J Lipid Res 1994;35:2060-2068.
29.
Ponec M, Weerheim A, Lankhorst P, Wertz P: New acylceramide in native and reconstituted epidermis. J Invest Dermatol 2003;120:581-588.
30.
Munoz-Garcia A, Ro J, Brown JC, Williams JB: Cutaneous water loss and sphingolipids in the stratum corneum of house sparrows, Passer domesticus L., from desert and mesic environments as determined by reverse phase high-performance liquid chromatography coupled with atmospheric pressure photospray ionization mass spectrometry. J Exp Biol 2008;211:447-458.
31.
Joo KM, Nam GW, Park SY, Han JY, Jeong HJ, Lee SY, Kim HK, Lim KM: Relationship between cutaneous barrier function and ceramide species in human stratum corneum. J Dermatol Sci 2010;60:47-50.
32.
Van Smeden J, Hoppel L, van den Heijden R, Hankemeier T, Vreeken BJ, Bouwstra JA: LC/MS analysis of stratum corneum lipids: ceramide profiling and discovery. J Lipid Res 2011;52:1211-1221.
33.
Di Nardo A, Wertz PW, Giannetti A, Seidenari S: Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol (Stockh) 1998;78:27-30.
34.
Melton JL, Wertz PW, Swartzendruber DC, Downing DT: Effects of essential fatty acid deficiency on O-acylsphingolipids and transepidermal water loss in young pigs. Biochim Biophys Acta 1987;921:191-197.
35.
Madison KC, Swartzendruber DC, Wertz PW, Downing DT: Presence of intact intercellular lamellae in the upper layers of the stratum corneum. J Invest Dermatol 1987;88:714-718.
36.
White SH, Mirejovsky D, King GI: Structure of lamellar lipid domains and corneocyte envelopes of murine stratum corneum: an X-ray diffraction study. Biochemistry 1988;27:3725-3732.
37.
Bouwstra JA, Gooris GS, van der Spek JA, Bras W: Structural investigations of human stratum corneum by small-angle X-ray scattering. J Invest Dermatol 1991;97:1005-1012.
38.
Bouwstra JA, Gooris GS, van der Spek JA, Lavrijsen S, Bras W: The lipid and protein structure of mouse stratum corneum: a wide and small angle diffraction study. Biochim Biophys Acta 1994;1212:183-192.
39.
McIntosh TJ, Stewart ME, Downing DT: X-ray diffraction analysis of isolated skin lipids: reconstitution of intercellular lipid domains. Biochemistry 1996;35:3649-3653.
40.
Kuempel D, Swartzendruber DC, Squier CA, Wertz PW: In vitro reconstitution of stratum corneum lipid lamellae. Biochim Biophys Acta 1998;1372:135-140.
41.
Bouwstra JA, Gooris GS, Dubbelaar FE, Ponec M: Phase behavior of stratum corneum lipid mixtures based on human ceramides: the role of natural and synthetic ceramide 1. J Invest Dermatol 2002;118:606-617.
42.
Wertz PW: Changes in epidermal lipids and sebum secretion; in Dayan N (ed): Skin Aging Handbook. Norwich, Andrew, 2008, pp 91-104.
43.
Zheng Y, Yin H, Boeglin WE, Elias PM, Crumrine D, Beier DR, Brash AR: Lipoxygenases mediate the effect of essential fatty acid in skin barrier formation. J Biol Chem 2011;286:24046-24056.
44.
Nemes Z, Marekov LN, Fesus L, Steinert PM: A novel function for transglutaminase 1: attachment of long-chain omega-hydroxyceramides to involucrin by ester bond formation. Proc Natl Acad Sci USA 1999;96:8402-8407.
45.
Long SA, Wertz PW, Strauss JS, Downing DT: Human stratum corneum polar lipids and desquamation. Arch Dermatol Res 1985;277:284-287.
46.
Lowther J, Naismith JH, Dunn TM, Campopiano DJ: Structural, mechanistic and regulatory studies of serine palmitoyltransferase. Biochem Soc Trans 2012;40:547-554.
47.
Goedeke L, Fernandez-Hernando C: Regulation of cholesterol homeostasis. Cell Mol Life Sci 2012;69:915-930.
48.
Lane MD, Moss J, Polakis SE: Acetyl coenzyme A carboxylase. Curr Top Cell Regul 1974;8:139-195.
49.
Bloch K: The biological synthesis of cholesterol. Science 1965;150:19-27.
50.
Gaylor JL: Membrane-bound enzymes of cholesterol synthesis from lanosterol. Biochem Biophys Res Commun 2002;292:1139-1146.
51.
Ponec M, Weerheim A, Kempenaar J, Mulder A, Gooris GS, Bouwstra J, Mommas AM: The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J Invest Dermatol 1997;109:348-355.
52.
Elias PM, Feingold KD: Coordinate regulation of epidermal differentiation and barrier homeostasis. Skin Pharmacol Appl Physiol 2001;14(suppl 1):28-34.
53.
Madison KC, Sando GN, Howard EJ, True CA, Gilbert D, Swartzendruber DC, Wertz PW: Lamellar granule biogenesis: a role for ceramide glucosyltransferase, lysosomal enzyme transport and the Golgi. J Invest Dermatol Symp Proc 1998;3:80-86.
54.
Freinkel RK, Traczyk TN: Lipid composition and acid hydrolase content of lamellar granules of fetal rat epidermis. J Invest Dermatol 1985;85:295-298.
55.
Grayson S, Johnson-Winegar AG, Wintroub BU, Isseroff RR, Epstein EH Jr, Elias PM: Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization. J Invest Dermatol 1985;85:289-294.
56.
Golden GM, Guzek DB, Harris RR, McKie JE, Potts RO: Lipid thermotropic transitions in human stratum corneum. J Invest Dermatol 1986;86:255-259.
57.
Bouwstra JA, Gooris GS, Bras W, Downing DT: Lipid organization in pig stratum corneum. J Lipid Res 1995;36:685-695.
58.
Bouwstra JA, Dubbelaar FE, Gooris GS, Ponec M: The lipid organization in the skin barrier. Acta Derm Venereol Suppl 2000;208:23-30.
59.
Gorcea M, Hadgraft J, Moore DJ, Lane ME: Fourier transform infrared spectroscopy studies of the lipid domain formation in normal and ceramide deficient stratum corneum lipid models. Int J Pharm 2012;435:63-68.
60.
Kwak S, Brief E, Langlais D, Kitson N, Lafleur M, Thewalt J: Ethanol perturbs lipid organization in models of stratum corneum membranes: an investigation combining scanning calorimetry, infrared and 2H NMR spectroscopy. Biochim Biophys Acta 2012;1818:1420-1419.
61.
Bouwstra JA, Cheng K, Gooris GS, Weerheim A, Ponec M: The role of ceramides 1 and 2 in the stratum corneum lipid organization. Biochim Biophys Acta 1996;1300:177-186.
62.
Bouwstra JA, Gooris GS, Dubbelaar FE, Weerheim A, Ijzerman AP, Ponec M: Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J Lipid Res 1998;39:186-196.
63.
Pilgram GS, Van Pelt AM, Spies F, Bouwstra JA, Koerten HK: Cryo-electron diffraction as a tool to study local variations in the lipid organization of human stratum corneum. J Microsc 1998;189:71-78.
64.
Pilgram GS, Van Pelt AM, Spies F, Bouwstra JA, Koerten HK: Electron diffraction provides new information on human stratum corneum lipid organization studied in relation to depth and temperature. J Invest Dermatol 1999;113:403-409.
65.
Elias PM, Wakefield JS: Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol 2011;41:282-295.
66.
Thyssen JP, Godoy-Gijon E, Elias PM: Ichthyosis vulgaris: the filaggrin mutation disease. Br J Dermatol 2013, E-pub ahead of print.
67.
Chamlin SL, Frieden IJ, Fowler A, Williams M, Kao J, Sheu M, Elias PM: Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis. Arch Dermatol 2001;137:1110-1112.
68.
Takagi Y, Nakagawa H, Higuchi K, Imokawa G: Characterization of surfactant-induced skin damage through barrier recovery induced by pseudoacylceramides. Dermatology 2005;211:128-134.
69.
Vavrova K, Hrabalek A, Mac-Mary S, Humbert P, Muret P: Ceramide analogue 14S24 selectively recovers perturbed human skin barrier. Br J Dermatol 2007;157:704-712.
70.
Pennick G, Chavan B, Summers B, Rawlings AV: The effect of an amphiphilic self-assembling lipid lamellar phase on the relief of dry skin. Int J Cosmet Sci 2012;34:567-574.
71.
Chan A, Hollerin WM, Ferguson T, Crumrine D, Goker-Alpan O, Schiffmann R, Tayebi N, Ginns EI, Elias PM, Sidransky E: Skin ultrastructural findings in type 2 Gaucher disease: diagnostic implications. Mol Genet Metab 2011;104:631-636.
72.
Yoshida N, Sawada E, Imokawa G: A reconstructed human epidermal keratinization culture model to characterize ceramide metabolism in the stratum corneum. Arch Dermatol Res 2012;304:563-577.
73.
Borkowski AW, Park K, Uchida Y, Gallo RL: Activation of TLR3 in keratinocytes increases expression of genes involved in formation of the epidermis, lipid accumulation and epidermal organelles. J Invest Dermatol 2013, E-pub ahead of print.
74.
Iwai I, Han H, den Hollander L, Svensson S, Ofverstedt LG, Anwar J, Brewer J, Bloksgaard M, Laloeuf A, Nosek D, Masich S, Bagatolli LA, Skoglund U, Norlen L: The human skin barrier is organized as stacked bilayers of fully extended ceramides with cholesterol molecules associated with the ceramide sphingoid moiety. J Invest Dermatol 2012;132:2215-2225.
75.
Lotte C, Patouillet C, Zanini M, Messager A, Rouget R: Permeation and skin absorption: reproducibility of various industrial reconstructed human skin models. Skin Pharmacol Appl Skin Physiol 2002;15S1:18-30.
76.
Marjuka Suhonen T, Pasonen-Seppanen S, Kirjavainen M, Tammi M, Tammi R, Urtti A: Epidermal cell culture model derived from rat keratinocytes with permeability characteristics comparable to cadaver skin. Eur J Pharm Sci 2003;20:107-113.
77.
Groen D, Poole DS, Gooris GS, Bouwstra JA: Investigating the barrier function of skin lipid models with varying lipid compositions. Eur J Pharm Biopharm 2011;79:334-342.
78.
Potts RO, Guy RH: A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm Res 1995;12:1628-1633.
79.
Mitragotri S, Anissimov YG, Bunge AL, Frasch HF, Guy RH, Hadgraft J, Kasting GB, Lane ME, Roberts MS: Mathematical models of skin permeability: an overview. Int J Pharm 2011;418:115-129.
80.
Das C, Noro MG, Olmsted PD: Simulation studies of stratum corneum lipid mixtures. Biophys J 2009;97:1941-1951.
81.
Hadley KR, McCabe C: A coarse-grained model for amorphous and crystalline fatty acids. J Chem Phys 2010;132:134505.
82.
Brave A, Gupta A, Solapure SM, Kumar A, Ramachandran V, Seshadri K, Vali S, Datta S: A kinetic platform for in silico modeling of the metabolic dynamics in Escherichia coli. Adv Appl Bioinform Chem 2010;3:97-110.
83.
Harvey LE, Kohlgraf K, Mehalick LA, Raina M, Recker EN, Radhakrishnan S, Prasad SA, Vida R, Progulske-Fox A, Cavanaugh JE, Vali S, Brogden KA: Defensin DEFB103 bidirectionally regulated chemokine and cytokine responses to a pro-inflammatory stimulus. Sci Rep 2013;2:1232.
84.
Christley S, Lee B, Dai X, Nie Q: Integrative multicellular biological modeling: a case study of 3D epidermal development using GPU algorithms. BMC Syst Biol 2010;9:107.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.